World's Best Scientists 2026 revealed!
Rainer H. Böger

Rainer H. Böger

D-Index & Metrics

Medicine

D-Index
88
Citations
29606
World Ranking
13126
National Ranking
700

Overview

Rainer H. Böger is affiliated with Universität Hamburg in Germany. Their research is primarily situated at the intersection of medicine and biochemistry, genetics, and molecular biology, with 105 and 41 publications respectively in these fields. Their work spans several specialized subfields including cardiology and cardiovascular medicine, physiology, molecular biology, pulmonary and respiratory medicine, and endocrine and autonomic systems.

The scientist's research topics cover a range of specific areas including nitric oxide and endothelin effects, high altitude and hypoxia, circadian rhythm and melatonin, neuroscience of respiration and sleep, cardiovascular issues in pregnancy, heart failure treatment and management, and blood pressure and hypertension studies.

Frequent coauthors in their collaborative work include Juliane Hannemann, Edzard Schwedhelm, Chi-un Choe, Lena Schmidt-Hutten, and Nikolaus Marx. Publication venues where Böger has contributed multiple studies include Scientific Reports, Journal of Clinical Medicine, Amino Acids, Pulmonary Circulation, and Frontiers in Physiology.

Selected recent papers exemplifying the scope and focus of their work are:

  • Male fetal sex is associated with low maternal plasma anti-inflammatory cytokine profile in the first trimester of healthy pregnancies, 2020, published in Cytokine
  • Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients, 2021, published in Scientific Reports
  • Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study, 2021, published in Acta Diabetologica
  • Dual role of the L-arginine-ADMA-NO pathway in systemic hypoxic vasodilation and pulmonary hypoxic vasoconstriction, 2020, published in Pulmonary Circulation
  • Dysregulation of the Nitric Oxide/Dimethylarginine Pathway in Hypoxic Pulmonary Vasoconstriction-Molecular Mechanisms and Clinical Significance, 2022, published in Frontiers in Medicine

Best Publications

  • Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction Its Role in Hypercholesterolemia

    Rainer H. Böger;Stefanie M. Bode-Böger;Andrzej Szuba;Philip S. Tsao

  • Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study

    Carmine Zoccali;Stefanie M Bode-Böger;Francesca Mallamaci;Frank Antonio Benedetto

  • Opioids and the management of chronic severe pain in the elderly: Consensus statement of an international expert panel with focus on the six clinically most often used world health organization step III opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

    Joseph Pergolizzi;Rainer H. Böger;Keith Budd;Albert Dahan

  • LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases.

    Rainer H. Böger;Karsten Sydow;Jürgen Borlak;Thomas Thum

  • Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

    Edzard Schwedhelm;Renke Maas;Ralf Freese;Donald Jung

  • The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

    Rainer H Böger

  • Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.

    Jan T. Kielstein;Rainer H. Böger;Stefanine M. Bode-Böger;Jürgen Schäffer

  • Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease

    Jan T. Kielstein;Rainer H. Böger;Stefanie M. Bode-Böger;Jürgen C. Frölich

  • The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease

    Latika Sibal;Sharad C Agarwal;Philip D Home;Rainer H Boger

  • Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

    Rainer H. Böger;Lisa M. Sullivan;Lisa M. Sullivan;Edzard Schwedhelm;Thomas J. Wang;Thomas J. Wang

  • Asymmetric Dimethylarginine, C-Reactive Protein, and Carotid Intima-Media Thickness in End-Stage Renal Disease

    Carmine Zoccali;Francesco Antonio Benedetto;Renke Maas;Francesca Mallamaci

  • Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia

    Rainer H. Böger;Stefanie M. Bode-Böger;Karsten Sydow;Donald D. Heistad

  • Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.

    Volker Rudolph;René P. Andrié;Tanja K. Rudolph;Kai Friedrichs

  • Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.

    R H Böger;C Skamira;S M Bode-Böger;G Brabant

  • Dietary l-Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits Comparison With Lovastatin

    Rainer H. Böger;Stefanie M. Bode-Böger;Ralf P. Brandes;Laddaval Phivthong-ngam

  • Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.

    Francesco Perticone;Angela Sciacqua;Raffaele Maio;Maria Perticone

  • Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use.

    G I Köhler;S M Bode-Böger;R Busse;M Hoopmann

  • An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes.

    Rainer H Böger;Stefanie M Bode-Böger;Philip S Tsao;Patrick S Lin

  • Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.

    Bernhard Schieffer;Christoph Bünte;Jana Witte;Kirsten Hoeper

  • Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond

    Rainer H. Böger

Frequent Co-Authors

Ramachandran S. Vasan
Ramachandran S. Vasan The University of Texas Health Science Center at San Antonio
Christian Gerloff
Christian Gerloff University Medical Center Hamburg-Eppendorf
Thomas Münzel
Thomas Münzel Johannes Gutenberg University of Mainz
Peter J. Grant
Peter J. Grant University of Leeds
Thomas Meinertz
Thomas Meinertz Universität Hamburg
Stefan Blankenberg
Stefan Blankenberg Universität Hamburg
Stephan Baldus
Stephan Baldus University of Cologne
Tanja Zeller
Tanja Zeller Universität Hamburg
John P. Cooke
John P. Cooke Houston Methodist
Lisa M. Sullivan
Lisa M. Sullivan Boston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering Medicine in the USA, exploring alternative and flexible educational paths can expand career options in healthcare. Online nursing and medical programs have become increasingly popular, providing accessibility for those who may balance work, family, or other commitments.

Many learners start by enrolling in online nursing courses, gaining foundational clinical skills and theoretical knowledge essential for today’s healthcare workforce. Registered nurses seeking career advancement can pursue rn to bsn online programs to deepen their expertise and unlock supervisory or specialized roles.

Those interested in becoming advanced practitioners can look into nurse practitioner programs. These programs train nurses for high-responsibility positions in diagnostics, patient care, and even leadership. For nurses aspiring to the highest level of practice, the cheapest dnp programs online provide a cost-effective pathway to doctoral credentials, preparing graduates for roles in education, research, or administration.

Online degree options make it possible for more people to enter or progress within the healthcare sector. Exploring the right program can open doors to meaningful, in-demand careers across the medical field.

Best Scientists Citing Rainer H. Böger

Trending Scientists

Recently Published Articles